The 36-month beta value for ICU is at -1.03. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ICU is 4.29M, and currently, shorts hold a 8.74% of that float. The average trading volume for ICU on January 16, 2025 was 232.75K shares.
ICU) stock’s latest price update
The stock price of SeaStar Medical Holding Corp (NASDAQ: ICU) has plunged by -5.24 when compared to previous closing price of 1.91, but the company has seen a -11.71% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-01-13 that Study to be conducted under $3.6 million NIH grant DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to evaluate the safety and initial efficacy of SeaStar Medical’s Selective Cytopheretic Device (SCD-ADULT) in reducing inflammation in adult patients with acute heart failure with worsening renal function due to cardiorenal syndrome or severe right ventricular failure awaiting a left ventricular assist device (LVAD) implantation. This feasibility study is expected to enroll 20 patients at up to five clinical sites and will be funded by a previously announced $ 3.6 million National Institutes of Health (NIH) grant awarded to Innovative BioTherapies (IBT), which is led by SCD inventor H.
ICU’s Market Performance
SeaStar Medical Holding Corp (ICU) has experienced a -11.71% fall in stock performance for the past week, with a -4.23% drop in the past month, and a -55.85% drop in the past quarter. The volatility ratio for the week is 7.92%, and the volatility levels for the past 30 days are at 7.33% for ICU. The simple moving average for the last 20 days is -9.16% for ICU stock, with a simple moving average of -72.25% for the last 200 days.
ICU Trading at -18.24% from the 50-Day Moving Average
After a stumble in the market that brought ICU to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.78% of loss for the given period.
Volatility was left at 7.33%, however, over the last 30 days, the volatility rate increased by 7.92%, as shares sank -9.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -41.61% lower at present.
During the last 5 trading sessions, ICU fell by -11.71%, which changed the moving average for the period of 200-days by -90.14% in comparison to the 20-day moving average, which settled at $1.9925. In addition, SeaStar Medical Holding Corp saw -6.70% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ICU starting from Chung Kevin, who purchase 4,250 shares at the price of $1.99 back on Nov 18 ’24. After this action, Chung Kevin now owns 13,685 shares of SeaStar Medical Holding Corp, valued at $8,458 using the latest closing price.
Chung Kevin, the Chief Medical Officer of SeaStar Medical Holding Corp, purchase 1,000 shares at $4.26 during a trade that took place back on Sep 30 ’24, which means that Chung Kevin is holding 9,435 shares at $4,258 based on the most recent closing price.
Stock Fundamentals for ICU
Current profitability levels for the company are sitting at:
- -235.56 for the present operating margin
- 1.0 for the gross margin
The net margin for SeaStar Medical Holding Corp stands at -445.38. The total capital return value is set at 7.81.
Currently, EBITDA for the company is -11.14 million with net debt to EBITDA at 0.07. When we switch over and look at the enterprise to sales, we see a ratio of 88.18. The receivables turnover for the company is 1.0for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.54.
Conclusion
In conclusion, SeaStar Medical Holding Corp (ICU) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
